Upgrade to SI Premium - Free Trial

BSX's ACCELERATE Study Questions Positive for Nevro (NVRO) - Northland Capital

February 2, 2017 1:13 PM
Northland Capital Markets analyst Suraj Kalia said a lack of Clarity on Boston Scientific's (NYSE: BSX) ACCELERATE Study is a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles